Clinical Trial: Efficacy and Safety Study of Abnoba Viscum F 20mg in Malignant Pleural Effusion Patients
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: A Phase 3, Multi-Center, Single-Arm, Open-Label Study For The Safety And Efficacy Of Mistletoe Extract (AbnobaViscum® Injection) In Malignant Pleural Effusions
Brief Summary: Phase 3, non-randomized, Multicenter, single arm study to assess efficacy and safety of Abnoba viscum F 20mg in patients with malignant pleural effusion
Detailed Summary:
Sponsor: Abnoba Korea
Current Primary Outcome: Efficacy [ Time Frame: 4 weeks ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Abnoba Korea
Dates:
Date Received: July 14, 2014
Date Started: January 2011
Date Completion:
Last Updated: July 21, 2014
Last Verified: July 2014